EvaluatePharma recently forecasted the 10 drugmakers that may have the highest worldwide prescription drug sales by 2026. Here are their predictions:
- Roche ($61 billion)
- Johnson & Johnson ($56.1 billion)
- Novartis ($54.8 billion)
- Merck & Co. ($53.2 billion)
- AbbVie ($52.7 billion)
- Pfizer ($51.1 billion)
- Bristol-Myers Squibb ($44.7 billion)
- Sanofi ($41.7 billion)
- AstraZeneca ($41 billion)
- GlaxoSmithKline ($40.8 billion)
More articles on pharmacy:
NIH updates remdesivir treatment guidelines
J&J to start human trials for COVID-19 vaccine this week
Growing number of polls find Americans hesitant about getting a future COVID-19 vaccine
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.